Zhejiang Sunflower Great Health Co., Ltd.
300111.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.31B
Close$
$0.60
82.3% downside
Current Fair Value
82.3% downsideOvervalued by 82.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.31 Billion |
|---|---|
| Enterprise Value | $3.92 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.49 |
| Outstanding Shares | 1,287,210,714 |
Return
| Return on Equity | -2.68% |
|---|---|
| Return on Assets | -1.82% |
| Return on Invested Capital | -0.83% |
Valuation & Multiples
| P/E Ratio | -239.29 |
|---|---|
| PEG | 36.48 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 16.61 |
| Enterprise Value to EBIT | -556.4 |
| Enterprise Value to Net Income | -219 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Sunflower Great Health Co., Ltd.
303 employees
CEO: Hua Xin Shi Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tabl...